Related articles

• Article

  JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.

  Blood. 2014 Mar 6;123(10):1544-51.

• Article

  Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations.

  Haematologica. 2015 Jul 1; 100 (7): 893-7.

• Article

  Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutations.

  Leuk. Res. 2015 May 1; 39 (5): 510-4.

Show more related articles...